This company’s main candidates include tovecimig (CTX-009), a bispecific antibody targeting DLL4 and VEGF-A; CTX-471, a CD137 agonist; and CTX-10726, a PD-1 x VEGF-A bispecific antibody.

In 2013 I received my PhD from the University of Cambridge where, as a Marie Curie Fellow in the lab of Professor Willem Ouwehand, I used the zebrafish model for studying regulators of haematopoiesis.

Tim is Professor of Cardiovascular Medicine at the University of Sheffield and a consultant Cardiologist at Sheffield Teaching Hospitals NHS Foundation Trust. His national roles include Associate ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Herpesviruses require the host transcriptional ...

The campus visit is one of the most important parts of your college selection process.

Department of Rheumatology, Translational Research Group, Dublin Academic Medical Centre, St Vincent's University Hospital, Dublin, Ireland Correspondence to Dr Ursula Fearon, Department of ...